(Q53444102)

14 May 2018

title

Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania. (English)

1 reference

14 May 2018

author name string

Mikhail Kalinichev

series ordinal

1

1 reference

14 May 2018

Lee A Dawson

series ordinal

2

1 reference

14 May 2018

publication date

6 January 2011

1 reference

14 May 2018

The International Journal of Neuropsychopharmacology

published in

1 reference

14 May 2018

volume

14

1 reference

14 May 2018

issue

8

1 reference

14 May 2018

page(s)

1051-1067

1 reference

14 May 2018

The staircase test in mice: A simple and efficient procedure for primary screening of anxiolytic agents

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Lithium does not attenuate the effects of D-amphetamine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

https://api.crossref.org/works/10.1017%2FS1461145710001495

1 reference

7 January 2021

Looking at lithium: molecular moods and complex behaviour

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Lithium plus reserpine in refractory manic patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Schizophrenia as a GSK-3 dysregulation disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

A molecular mechanism for the effect of lithium on development

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Locomotor reactivity to a novel environment and sensitivity to MK-801 in five strains of mice

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Toward constructing an endophenotype strategy for bipolar disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Targeting glycogen synthase kinase-3 as an approach to develop novel mood-stabilising medications

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Genetic Theorizing and Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

The endophenotype concept in psychiatry: etymology and strategic intentions

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Attenuation of high sweet solution preference by mood stabilizers: a possible mouse model for the increased reward-seeking domain of mania

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Models of mania: from facets to domains and from animal models to model animals

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Efficacy of olanzapine and haloperidol in an animal model of mania.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Different behaviors and different strains: potential new ways to model bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Modelling facets of mania--new directions related to the notion of endophenotypes.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

The armamentarium of treatments for bipolar disorder: a review of the literature

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Kinases as drug targets in the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Lithium prevention of amphetamine-induced ?manic? excitement and of reserpine-induced ?depression? in mice: Possible role of 2-phenylethylamine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Olanzapine compared to lithium in mania: a double-blind randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

The effect of lithium on amphetamine-induced locomotor stimulation

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Hyperactivity and impaired response habituation in hyperdopaminergic mice

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Valproate attenuates dextroamphetamine-induced subjective changes more than lithium

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Effects of chronic lithium treatment on brain monoamine metabolism and amphetamine-induced locomotor stimulation in rats

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Akt/GSK3 signaling in the action of psychotropic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

The effect of reserpine on the duration of manic attacks

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Anxiety-like and exploratory behaviors of isolation-reared mice in the staircase test.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

In vivo evidence that genetic background controls impulse-dependent dopamine release induced by amphetamine in the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

How can drug discovery for psychiatric disorders be improved?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Antipsychotic agents in the treatment of bipolar mania

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Central and peripheral effects of lithium on amphetamine-induced hyperactivity in rats

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001495

7 January 2021

10.1017/S1461145710001495

Identifiers

DOI

1 reference

14 May 2018

release_eu64yaxsxfbo5juisyre5xguua

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eu64yaxsxfbo5juisyre5xguua

24 November 2022

mapped directly with Wikidata item

PubMed ID

21208504

1 reference

14 May 2018